5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Europe Diagnostic Imaging Equipment Market is Segmented on the basis of Modality, Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Other Applications), End-User and Geography
The major factors for the growth of the European diagnostic imaging equipment market include the increase in the geriatric population and the rising prevalence of chronic diseases, technological advancement in imaging modalities, and the rising adoption of medical imaging devices.
The increase in the geriatric population and the rising prevalence of chronic diseases is one of the major factors boosting the growth of the market. According to the estimates of the World Aging Report 2017, published by the United Nations, in Germany, approximately 28.0% of the population was aged 60 years and over, in 2017. This percentage is expected to become 37.6%, by 2050. Furthermore, as per the data published by the Office for National Statistics, around 18.2% of the population in the United Kingdom was aged 65 years or over, in mid-2017, and this is projected to grow to 20.7% by 2027. Thus, the rising aging population is expected to increase the prevalence of various chronic diseases, resulting in the high demand for medical imaging devices.
For instance, according to the estimates of the Globocan, in 2018, there were 446,942 new cancer cases in the United Kingdom. Prostate, breast, lung, colon, and skin cancers are the most common types of cancers detected in the United Kingdom. Hence all these factors have helped the growth of the diagnostic imaging equipment market in Europe, and is expected to boost the growth in the region in future as well.
As per the scope of the report, the diagnostic imaging equipment market covers a wide array of medical devices used for diagnostic purposes. It has a vast range of applications in the oncological, orthopedic, gastro, and gynecological fields.
|By End User|
|Other End Users|
Report scope can be customized per your requirements. Click here.
Diagnostic imaging plays a vital role in interventional oncology (with rising opportunities to diagnose and treat in a targeted and minimally or non-invasive manner) as well as in chemo and radiation therapy. The tools, such as CT, are the highly beneficial and preferred method of imaging for many conditions, including trauma patients. Comparatively, PET is mostly preferred as compared to SPECT, and there are hybrid medical devices also available such as PET/CT or PET/MRI.
The use is expected to increase in the future due to the increasing incidence of cancer in Europe. As per a 2018 study by the International Agency for Research on Cancer, there were nearly 4.2 million cases of cancer in 2018, which is expected to increase to more than 4.8 million by 2030. This will increase the demand for diagnostic imaging equipment, which will boost the market growth in the region.
To understand key trends, Download Sample Report
The market studied is a fragmented one, owing to the presence of various players. Some of the market players are Canon Medical Systems Corporation, Carestream Health Inc., Esaote SpA, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi Medical Systems, Hologic Corporation, Koninklijke Philips NV, Shimadzu Medical, and Siemens Healthineers.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Geriatric Population and Rising Prevalence of Chronic Diseases
4.2.2 Technological Advancement in Imaging Modalities
4.2.3 Rising Adoption of Medical Imaging Devices
4.3 Market Restraints
4.3.1 High Cost of Advanced Diagnostic Imaging Devices
4.3.2 Dearth of Radiologists
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Modality
18.104.22.168 Low and Mid Field MRI Systems (
5.1.2 Computed Tomography
22.214.171.124 Low End Scanners (~16-Slice)
126.96.36.199 Mid Range Scanners (~64-Slice)
188.8.131.52 High End Scanners (128-Slice and More)
184.108.40.206 2D Ultrasound
220.127.116.11 3D Ultrasound
18.104.22.168 Analog Systems
22.214.171.124 Digital Systems
5.1.5 Nuclear Imaging
126.96.36.199 Positron Emission Tomography (PET)
188.8.131.52 Single Photon Emission Computed Tomography (SPECT)
5.2 By Application
5.2.7 Other Applications
5.3 By End User
5.3.2 Diagnostic Centers
5.3.3 Other End Users
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Canon Medical Systems Corporation
6.1.2 Carestream Health Inc.
6.1.3 Esaote SpA
6.1.4 FUJIFILM Holdings Corporation
6.1.5 GE Healthcare
6.1.6 Hitachi Medical Systems
6.1.7 Hologic Corporation
6.1.8 Koninklijke Philips NV
6.1.9 Shimadzu Medical
6.1.10 Siemens Healthineers
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments